These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11168910)

  • 1. Pharmacodynamics of warfarin in cats.
    Smith SA; Kraft SL; Lewis DC; Melethil S; Freeman LC
    J Vet Pharmacol Ther; 2000 Dec; 23(6):339-44. PubMed ID: 11168910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
    Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P
    Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible influences of ginseng on the pharmacokinetics and pharmacodynamics of warfarin in rats.
    Zhu M; Chan KW; Ng LS; Chang Q; Chang S; Li RC
    J Pharm Pharmacol; 1999 Feb; 51(2):175-80. PubMed ID: 10217316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of aprepitant on the pharmacokinetics and pharmacodynamics of warfarin.
    Depré M; Van Hecken A; Oeyen M; De Lepeleire I; Laethem T; Rothenberg P; Petty KJ; Majumdar A; Crumley T; Panebianco D; Bergman A; de Hoon JN
    Eur J Clin Pharmacol; 2005 Jul; 61(5-6):341-6. PubMed ID: 15983826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children.
    Takahashi H; Ishikawa S; Nomoto S; Nishigaki Y; Ando F; Kashima T; Kimura S; Kanamori M; Echizen H
    Clin Pharmacol Ther; 2000 Nov; 68(5):541-55. PubMed ID: 11103757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of taranabant, a cannabinoid-1 receptor inverse agonist, on pharmacokinetics and pharmacodynamics of warfarin.
    Schwartz JI; Dunbar S; Yuan J; Li S; Gipson A; Rosko K; Johnson-Levonas AO; Lasseter KC; Addy C; Stoch AS; Wagner JA
    Adv Ther; 2008 Nov; 25(11):1175-90. PubMed ID: 18989636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma pharmacokinetics of warfarin enantiomers in cats.
    Smith SA; Kraft SL; Lewis DC; Freeman LC
    J Vet Pharmacol Ther; 2000 Dec; 23(6):329-37. PubMed ID: 11168909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cucurbitacin e, a tetracyclic triterpene compound from Cucurbitaceae, on the pharmacokinetics and pharmacodynamics of warfarin in rats.
    Ding T; Zhang Y; Chen A; Tang Y; Liu M; Wang X
    Basic Clin Pharmacol Toxicol; 2015 May; 116(5):385-9. PubMed ID: 25250504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of tecarfarin, a novel vitamin K antagonist oral anticoagulant.
    Albrecht D; Ellis D; Canafax DM; Combs D; Druzgala P; Milner PG; Midei MG
    Thromb Haemost; 2017 Apr; 117(4):706-717. PubMed ID: 28180234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin maintenance dose adjustment with indirect pharmacodynamic model in rats.
    Cao YG; Liu XQ; Chen YC; Hao K; Wang GJ
    Eur J Pharm Sci; 2007 Feb; 30(2):175-80. PubMed ID: 17169538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
    Jiang X; Williams KM; Liauw WS; Ammit AJ; Roufogalis BD; Duke CC; Day RO; McLachlan AJ
    Br J Clin Pharmacol; 2004 May; 57(5):592-9. PubMed ID: 15089812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of nebicapone on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
    Almeida L; Falcão A; Vaz-da-Silva M; Nunes T; Santos AT; Rocha JF; Neta C; Macedo T; Fontes-Ribeiro C; Soares-da-Silva P
    Eur J Clin Pharmacol; 2008 Oct; 64(10):961-6. PubMed ID: 18679669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of etoricoxib on the pharmacodynamics and pharmacokinetics of warfarin.
    Schwartz JI; Agrawal NG; Hartford AH; Cote J; Hunt TL; Verbesselt R; Eckols DR; Gottesdiener KM
    J Clin Pharmacol; 2007 May; 47(5):620-7. PubMed ID: 17442687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oral vitamin K on S- and R-warfarin pharmacokinetics and pharmacodynamics: enhanced safety of warfarin as a CYP2C9 probe.
    Kim JS; Nafziger AN; Gaedigk A; Dickmann LJ; Rettie AE; Bertino JS
    J Clin Pharmacol; 2001 Jul; 41(7):715-22. PubMed ID: 11452703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of cimetidine on the steady-state pharmacokinetics and pharmacodynamics of warfarin in humans.
    Niopas I; Toon S; Aarons L; Rowland M
    Eur J Clin Pharmacol; 1999 Jul; 55(5):399-404. PubMed ID: 10456491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irbesartan does not affect the steady-state pharmacodynamics and pharmacokinetics of warfarin.
    Mangold B; Gielsdorf W; Marino MR
    Eur J Clin Pharmacol; 1999 Oct; 55(8):593-8. PubMed ID: 10541778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of CYP2C19 genotypes on the pharmacokinetics of warfarin enantiomers.
    Uno T; Sugimoto K; Sugawara K; Tateishi T
    J Clin Pharm Ther; 2008 Feb; 33(1):67-73. PubMed ID: 18211619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of linagliptin on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.
    Graefe-Mody EU; Brand T; Ring A; Withopf B; Stangier J; Iovino M; Woerle HJ
    Int J Clin Pharmacol Ther; 2011 May; 49(5):300-10. PubMed ID: 21543033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vorapaxar, an oral PAR-1 receptor antagonist, does not affect the pharmacokinetics and pharmacodynamics of warfarin.
    Kosoglou T; Zhu Y; Xuan F; Black L; Johnson-Levonas AO; Martinho M; Statkevich P; Cutler DL
    Eur J Clin Pharmacol; 2012 Nov; 68(11):1509-16. PubMed ID: 22476387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The alpha-glucosidase inhibitor voglibose (AO-128) does not change pharmacodynamics or pharmacokinetics of warfarin.
    Fuder H; Kleist P; Birkel M; Ehrlich A; Emeklibas S; Maslak W; Stridde E; Wetzelsberger N; Wieckhorst G; Lücker PW
    Eur J Clin Pharmacol; 1997; 53(2):153-7. PubMed ID: 9403289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.